Warning: The NCBI web site requires JavaScript to function. more...
Inflammation and breast cancer. Inflammatory component of mammary carcinogenesis in ErbB2 transgenic mice.
Calogero RA, Cordero F, Forni G, Cavallo F.
Breast Cancer Res. 2007;9(4):211. Review.
Related citations
Immunobiology of her-2/neu transgenic mice.
Pannellini T, Forni G, Musiani P.
Breast Dis. 2004;20:33-42. Review.
Gene expression profiling of cancer progression reveals intrinsic regulation of transforming growth factor-beta signaling in ErbB2/Neu-induced tumors from transgenic mice.
Landis MD, Seachrist DD, Montañez-Wiscovich ME, Danielpour D, Keri RA.
Oncogene. 2005 Aug 4;24(33):5173-90.
Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccination.
Pupa SM, Iezzi M, Di Carlo E, Invernizzi A, Cavallo F, Meazza R, Comes A, Ferrini S, Musiani P, Ménard S.
Cancer Res. 2005 Feb 1;65(3):1071-8.
Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells.
Kim A, Liu B, Ordonez-Ercan D, Alvarez KM, Jones LD, McKimmey C, Edgerton SM, Yang X, Thor AD.
Breast Cancer Res. 2005;7(5):R708-18. Epub 2005 Jul 6.
Gene-specific inhibition of breast carcinoma in BALB-neuT mice by active immunization with rat Neu or human ErbB receptors.
Masuelli L, Focaccetti C, Cereda V, Lista F, Vitolo D, Trono P, Gallo P, Amici A, Monaci P, Mattei M, Modesti M, Forni G, Kraus MH, Muraro R, Modesti A, Bei R.
Int J Oncol. 2007 Feb;30(2):381-92.
Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors.
Landis MD, Seachrist DD, Abdul-Karim FW, Keri RA.
Oncogene. 2006 Jun 1;25(23):3325-34. Epub 2006 Jan 23.
Changes associated with delay of mammary cancer by retinoid analogues in transgenic mice bearing c-neu oncogene.
Rao GN, Ney E, Herbert RA.
Breast Cancer Res Treat. 1999 Dec;58(3):241-54.
Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
Nguyen A, Rosner A, Milovanovic T, Hope C, Planutis K, Saha B, Chaiwun B, Lin F, Imam SA, Marsh JL, Holcombe RF.
Int J Oncol. 2005 Oct;27(4):949-56.
Intramammary application of non-methylated-CpG oligodeoxynucleotides (CpG) inhibits both local and systemic mammary carcinogenesis in female BALB/c Her-2/neu transgenic mice.
Mastini C, Becker PD, Iezzi M, Curcio C, Musiani P, Forni G, Cavallo F, Guzmán CA.
Curr Cancer Drug Targets. 2008 May;8(3):230-42.
Insertion of the DNA for the 163-171 peptide of IL1beta enables a DNA vaccine encoding p185(neu) to inhibit mammary carcinogenesis in Her-2/neu transgenic BALB/c mice.
Rovero S, Boggio K, Di Carlo E, Amici A, Quaglino E, Porcedda P, Musiani P, Forni G.
Gene Ther. 2001 Mar;8(6):447-52.
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity.
Spadaro M, Ambrosino E, Iezzi M, Di Carlo E, Sacchetti P, Curcio C, Amici A, Wei WZ, Musiani P, Lollini PL, Cavallo F, Forni G.
Clin Cancer Res. 2005 Mar 1;11(5):1941-52.
Dual role of AP-2gamma in ErbB-2-induced mammary tumorigenesis.
Jäger R, Friedrichs N, Heim I, Büttner R, Schorle H.
Breast Cancer Res Treat. 2005 Apr;90(3):273-80.
Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice.
Nanni P, Nicoletti G, De Giovanni C, Landuzzi L, Di Carlo E, Cavallo F, Pupa SM, Rossi I, Colombo MP, Ricci C, Astolfi A, Musiani P, Forni G, Lollini PL.
J Exp Med. 2001 Nov 5;194(9):1195-205.
Vaccination of fiber-modified adenovirus-transfected dendritic cells to express HER-2/neu stimulates efficient HER-2/neu-specific humoral and CTL responses and reduces breast carcinogenesis in transgenic mice.
Sas S, Chan T, Sami A, El-Gayed A, Xiang J.
Cancer Gene Ther. 2008 Oct;15(10):655-66. Epub 2008 Apr 18.
p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S, Tinnirello A, Di Stefano P, Bisarò B, Ambrosino E, Castellano I, Sapino A, Arisio R, Cavallo F, Forni G, Glukhova M, Silengo L, Altruda F, Turco E, Tarone G, Defilippi P.
Cancer Res. 2006 May 1;66(9):4672-80.
The transcription factor ATF3 acts as an oncogene in mouse mammary tumorigenesis.
Wang A, Arantes S, Yan L, Kiguchi K, McArthur MJ, Sahin A, Thames HD, Aldaz CM, Macleod MC.
BMC Cancer. 2008 Sep 22;8:268.
IkappaB kinase alpha kinase activity is required for self-renewal of ErbB2/Her2-transformed mammary tumor-initiating cells.
Cao Y, Luo JL, Karin M.
Proc Natl Acad Sci U S A. 2007 Oct 2;104(40):15852-7. Epub 2007 Sep 21.
neu/ERBB2 cooperates with p53-172H during mammary tumorigenesis in transgenic mice.
Li B, Rosen JM, McMenamin-Balano J, Muller WJ, Perkins AS.
Mol Cell Biol. 1997 Jun;17(6):3155-63.
Mammary glands reconstituted with Neu/ErbB2 transformed HC11 cells provide a novel orthotopic tumor model for testing anti-cancer agents.
Brandt R, Wong AM, Hynes NE.
Oncogene. 2001 Sep 6;20(39):5459-65.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on